Search Within

Serge K. Lyashchenko

Formats
  1. Journal Article (57)
  2. Meeting Abstract (45)
  3. Book Section (4)
  4. Review (4)
  5. Correspondence (1)
Groups
  1. Radiochemistry and Imaging Sciences Service (111)
  2. Radiology, Department of (111)
  3. GSK Faculty (98)
  4. Molecular Imaging and Therapy Service (91)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (83)
  6. Center for Pancreatic Cancer Research (82)

More Groups

People
  1. Jason Lewis (76)
  2. Neeta Pandit-Taskar (54)
  3. Steven Larson (47)
  4. Jorge Carrasquillo (37)
  5. Joseph O'Donoghue (33)
  6. Pat Zanzonico (33)

More People

Years
  1. 2025 (4)
  2. 2024 (14)
  3. 2023 (9)
  4. 2022 (8)
  5. 2021 (2)
  6. 2020 (11)

More Years

Publications
  1. Journal of Nuclear Medicine (28)
  2. Journal of Clinical Oncology (17)
  3. Neuro-Oncology (7)
  4. European Journal of Nuclear Medicine and Molecular Imaging (6)
  5. Clinical Cancer Research (5)
  6. Pediatric Blood and Cancer (5)

More Publications

Publishers
  1. Society of Nuclear Medicine (28)
  2. American Society of Clinical Oncology (17)
  3. Springer (11)
  4. Oxford University Press (10)
  5. American Association for Cancer Research (7)
  6. Wiley Periodicals, Inc (5)

More Publishers

Results (111)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Safety and efficacy of intraventricular (131)I-labeled monoclonal antibody 8H9 targeting the surface glycoprotein B7-H3 in patients with CNS/LM disease
    Meeting Abstract

    Kramer, K.; Kushner, B.; Modak, S.; Pandit-Taskar, N.; Tomlinson, U.; Donzelli, M.; Wolden, S.; Zanzonico, P.; Humm, J.; Haque, S.; more...
    Neuro-Oncology (2017)

    Fulltext@MSK | Save
  • Safety and efficacy of intraventricular (131)I-labeled monoclonal antibody 8H9 targeting the surface glycoprotein B7-H3 in patients with CNS/LM disease
    Meeting Abstract

    Kramer, K.; Kushner, B.; Modak, S.; Pandit-Taskar, N.; Tomlinson, U.; Donzelli, M.; Wolden, S.; Zanzonico, P.; Humm, J.; Haque, S.; more...
    Neuro-Oncology (2017)

    Fulltext@MSK | Save
  • (89)Zr-trastuzumab PET/CT for detection of human epidermal growth factor receptor 2-positive metastases in patients with human epidermal growth factor receptor 2-negative primary breast cancer
    Journal Article

    Ulaner, G. A.; Hyman, D. M.; Lyashchenko, S. K.; Lewis, J. S.; Carrasquillo, J. A.
    Clinical Nuclear Medicine (2017)

    Fulltext@MSK | Save
  • Biodistribution and radiation rose estimates for (89)Zr-DFO-HuMab-5B1 (MVT-2163) in CA19-9 positive cancer: First-in-man results
    Meeting Abstract

    O'Donoghue, J.; Lohrmann, C.; O'Reilly, E.; Yu, K.; Lowery, M.; Lyashchenko, S.; Pandit-Taskar, N.; Ruan, S.; Wu, L.; Teng, R.; more...
    Journal of Nuclear Medicine (2017)

    Fulltext@MSK | Save
  • First-in-human study of (89)Zr-DFO-HuMab-5B1 (MVT-2163) PET/CT imaging with and without HuMab-5B1 (MVT-5873) in patients with pancreatic cancer and other CA 19-9 positive malignancies
    Meeting Abstract

    Lohrmann, C.; O'Reilly, E.; ODonoghue, J.; Yu, K. H.; Pandit-Taskar, N.; Lyashchenko, S.; Ruan, S.; Wu, J.; DeNoble, P.; Carrasquillo, J.; more...
    Journal of Nuclear Medicine (2017)

    Fulltext@MSK | Save
  • Prospective clinical trial of (18)F-fluciclovine PET/CT for determining the response to neoadjuvant therapy in invasive ductal and invasive lobular breast cancers
    Journal Article

    Ulaner, G. A.; Goldman, D. A.; Corben, A.; Lyashchenko, S. K.; Gönen, M.; Lewis, J. S.; Dickler, M.
    Journal of Nuclear Medicine (2017)

    Fulltext@MSK | Save
  • A phase II study of radioimmunotherapy with intraventricular 131I-3F8 for medulloblastoma
    Meeting Abstract

    Kramer, K.; Pandit-Taskar, N.; Humm, J.; Zanzonico, P.; Haque, S.; Dunkel, I.; Wolden, S.; Donzelli, M.; Goldman, D.; Lewis, J.; more...
    Neuro-Oncology (2017)

    Fulltext@MSK | Save
  • Phase Ib study of codrituzumab in combination with sorafenib in patients with non-curable advanced hepatocellular carcinoma (HCC)
    Journal Article

    Abou-Alfa, G. K.; Yen, C. J.; Hsu, C. H.; O'Donoghue, J.; Beylergil, V.; Ruan, S.; Pandit-Taskar, N.; Gansukh, B.; Lyashchenko, S. K.; Ma, J.; more...
    Cancer Chemotherapy and Pharmacology (2017)

    Fulltext@MSK | Save
  • Radiolabeled gastrin-releasing-peptide receptor antagonist (68Ga-RM2) PET/CT in newly-diagnosed prostate cancer (PCa), compared and combined with multiparametric prostate MRI
    Meeting Abstract

    Michaud, L.; Sandler, I.; Beatty, B.; Gopalan, A.; Lyashchenko, S.; Taunk, N.; Lewis, J.; Hricak, H.; Vargas, A.; Touijer, K.; more...
    European Journal of Nuclear Medicine and Molecular Imaging (2016)

    Fulltext@MSK | Save
  • First-in-human imaging with (89)Zr-Df-IAB2M Anti-PSMA minibody in patients with metastatic prostate cancer: Pharmacokinetics, biodistribution, dosimetry, and lesion uptake
    Journal Article

    Pandit-Taskar, N.; O'Donoghue, J. A.; Ruan, S.; Lyashchenko, S. K.; Carrasquillo, J. A.; Heller, G.; Martinez, D. F.; Cheal, S. M.; Lewis, J. S.; Fleisher, M.; more...
    Journal of Nuclear Medicine (2016)

    Fulltext@MSK | Save